The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

EnteroBiotix Announces MHRA License Approval and Strengthened Senior Management Team
Pharma & Human Health

EnteroBiotix Announces MHRA License Approval and Strengthened Senior Management Team

SEP 10, 2018
Trying to Close the Stable Door After the Horse has Bolted
Editor's Choice

Trying to Close the Stable Door After the Horse has Bolted

SEP 10, 2018
Women with gas and bloating: Probiotic clinical trial outcomes
Biotics and Supplements

Women with gas and bloating: Probiotic clinical trial outcomes

SEP 6, 2018
Bloom Science and Biose industrie Announce Agreement to Initiate Manufacture Development of Promising Epilepsy Therapy Drug
Pharma & Human Health

Bloom Science and Biose industrie Announce Agreement to Initiate Manufacture Development of Promising Epilepsy Therapy Drug

SEP 6, 2018
Eagle Genomics Lands Microsoft Co-Sell Status for Mapping the Microbiome Using Artificial Intelligence
Pharma & Human Health

Eagle Genomics Lands Microsoft Co-Sell Status for Mapping the Microbiome Using Artificial Intelligence

SEP 6, 2018
A telephone for Your Microbiome: Setting the Stage for a Synthetic Microbiome
Editor's Choice

A telephone for Your Microbiome: Setting the Stage for a Synthetic Microbiome

SEP 4, 2018
OptiBiotix signs US pharmaceutical deal for its cholesterol reducing Lactobacillus plantarum strain
Finance

OptiBiotix signs US pharmaceutical deal for its cholesterol reducing Lactobacillus plantarum strain

SEP 4, 2018
Nutraceutical Corporation Partners with Microbiome Medicine Pioneer Dr. Raphael Kellman, MD
Biotics and Supplements

Nutraceutical Corporation Partners with Microbiome Medicine Pioneer Dr. Raphael Kellman, MD

SEP 3, 2018
Setting the stage for rapid and continual microbiome-focused innovation: An interview with BioCollective CEO Martha Carlin
Editor's Choice

Setting the stage for rapid and continual microbiome-focused innovation: An interview with BioCollective CEO Martha Carlin

SEP 2, 2018
Carbiotix closes pre-seed financing round
Finance

Carbiotix closes pre-seed financing round

AUG 31, 2018
Clalit Health Services & DayTwo Join Forces to Bring to Market Glycemic-Control Product Based on the Gut Microbiome
Pharma & Human Health

Clalit Health Services & DayTwo Join Forces to Bring to Market Glycemic-Control Product Based on the Gut Microbiome

AUG 29, 2018